Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-21

Clinical Trial Update: Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 study evaluating adding brinzolamide and timolol to travoprost for primary open-angle glaucoma or ocular hypertension; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide (Brinzolamide)
  • Timolol (timolol)
  • Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Primary Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED